{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:46:43Z","timestamp":1792716403936,"version":"4.5.0"},"reference-count":197,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41584-018-0125-2","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T13:57:47Z","timestamp":1543931867000},"page":"18-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair"],"prefix":"10.1038","volume":"15","author":[{"given":"Magali","family":"Cucchiarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Madry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"125_CR1","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/art.39970","volume":"69","author":"A Guermazi","year":"2017","unstructured":"Guermazi, A. et al. Brief report: partial- and full-thickness focal cartilage defects contribute equally to development of new cartilage damage in knee osteoarthritis: the multicenter osteoarthritis study. Arthritis Rheumatol. 69, 560\u2013564 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"125_CR2","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1177\/0363546517699846","volume":"45","author":"TL Sanders","year":"2017","unstructured":"Sanders, T. L. et al. High rate of osteoarthritis after osteochondritis dissecans fragment excision compared with surgical restoration at a mean 16-year follow-up. Am. J. Sports Med. 45, 1799\u20131805 (2017).","journal-title":"Am. J. Sports Med."},{"key":"125_CR3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.joca.2014.12.011","volume":"23","author":"EB Hunziker","year":"2015","unstructured":"Hunziker, E. B., Lippuner, K., Keel, M. J. & Shintani, N. An educational review of cartilage repair: precepts & practice \u2014 myths & misconceptions \u2014 progress & prospects. Osteoarthritis Cartilage 23, 334\u2013350 (2015).","journal-title":"Osteoarthritis Cartilage"},{"key":"125_CR4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrrheum.2014.157","volume":"11","author":"EA Makris","year":"2015","unstructured":"Makris, E. A., Gomoll, A. H., Malizos, K. N., Hu, J. C. & Athanasiou, K. A. Repair and tissue engineering techniques for articular cartilage. Nat. Rev. Rheumatol. 11, 21\u201334 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"125_CR5","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1177\/0363546515589167","volume":"44","author":"R Mundi","year":"2016","unstructured":"Mundi, R. et al. Cartilage restoration of the knee: a systematic review and meta-analysis of level 1 studies. Am. J. Sports Med. 44, 1888\u20131895 (2016).","journal-title":"Am. J. Sports Med."},{"key":"125_CR6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1053\/joca.2002.0801","volume":"10","author":"EB Hunziker","year":"2002","unstructured":"Hunziker, E. B. Articular cartilage repair: basic science and clinical progress. A review of the current state and prospects. Osteoarthritis Cartilage 10, 432\u2013463 (2002).","journal-title":"Osteoarthritis Cartilage"},{"key":"125_CR7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrrheum.2015.28","volume":"11","author":"CH Evans","year":"2015","unstructured":"Evans, C. H. & Huard, J. Gene therapy approaches to regenerating the musculoskeletal system. Nat. Rev. Rheumatol. 11, 234\u2013242 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"125_CR8","first-page":"820","volume":"39","author":"I Nita","year":"1996","unstructured":"Nita, I. et al. Direct gene delivery to synovium. An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum. 39, 820\u2013828 (1996).","journal-title":"An evaluation of potential vectors in vitro and in vivo. Arthritis Rheum."},{"key":"125_CR9","doi-asserted-by":"crossref","first-page":"1609685","DOI":"10.1155\/2017\/1609685","volume":"2017","author":"H Madry","year":"2017","unstructured":"Madry, H., Gao, L., Eichler, H., Orth, P. & Cucchiarini, M. Bone marrow aspirate concentrate-enhanced marrow stimulation of chondral defects. Stem Cells Int. 2017, 1609685 (2017).","journal-title":"Stem Cells Int."},{"key":"125_CR10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM199410063311401","volume":"331","author":"M Brittberg","year":"1994","unstructured":"Brittberg, M. et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331, 889\u2013895 (1994).","journal-title":"N. Engl. J. Med."},{"key":"125_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21060","volume":"21","author":"H Mistry","year":"2017","unstructured":"Mistry, H. et al. Autologous chondrocyte implantation in the knee: systematic review and economic evaluation. Health Technol. Assess. 21, 1\u2013294 (2017).","journal-title":"Health Technol. Assess."},{"key":"125_CR12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2106\/JBJS.15.01208","volume":"98","author":"G Knutsen","year":"2016","unstructured":"Knutsen, G. et al. A randomized multicenter trial comparing autologous chondrocyte implantation with microfracture: long-term follow-up at 14 to 15 years. J. Bone Joint Surg. Am. 98, 1332\u20131339 (2016).","journal-title":"J. Bone Joint Surg. Am."},{"key":"125_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/0363546517740575","author":"L Gao","year":"2017","unstructured":"Gao, L., Orth, P., Cucchiarini, M. & Madry, H. Autologous matrix-induced chondrogenesis: a systematic review of the clinical evidence. Am. J. Sports Med. https:\/\/doi.org\/10.1177\/0363546517740575 (2017).","journal-title":"Am. J. Sports Med."},{"key":"125_CR14","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/j.arthro.2016.05.038","volume":"32","author":"A Pareek","year":"2016","unstructured":"Pareek, A. et al. Osteochondral autograft transfer versus microfracture in the knee: a meta-analysis of prospective comparative studies at midterm. Arthroscopy 32, 2118\u20132130 (2016).","journal-title":"Arthroscopy"},{"key":"125_CR15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/0363546514565770","volume":"43","author":"GC Gracitelli","year":"2015","unstructured":"Gracitelli, G. C. et al. Fresh osteochondral allografts in the knee: comparison of primary transplantation versus transplantation after failure of previous subchondral marrow stimulation. Am. J. Sports Med. 43, 885\u2013891 (2015).","journal-title":"Am. J. Sports Med."},{"key":"125_CR16","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.38614","volume":"66","author":"S Lohmander","year":"2014","unstructured":"Lohmander, S. et al. Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 66, 1820\u20131831 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"125_CR17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.molmed.2017.08.002","volume":"23","author":"SS Adkar","year":"2017","unstructured":"Adkar, S. S. et al. Genome engineering for personalized arthritis therapeutics. Trends Mol. Med. 23, 917\u2013931 (2017).","journal-title":"Trends Mol. Med."},{"key":"125_CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/mt.2015.164","volume":"24","author":"X Chen","year":"2016","unstructured":"Chen, X. & Goncalves, M. A. Engineered viruses as genome editing devices. Mol. Ther. 24, 447\u2013457 (2016).","journal-title":"Mol. Ther."},{"key":"125_CR19","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/jgm.824","volume":"7","author":"M Cucchiarini","year":"2005","unstructured":"Cucchiarini, M. & Madry, H. Gene therapy for cartilage defects. J. Gene Med. 7, 1495\u20131509 (2005).","journal-title":"J. Gene Med."},{"key":"125_CR20","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1097\/00003086-200010001-00027","volume":"379","author":"CH Evans","year":"2000","unstructured":"Evans, C. H. et al. Using gene therapy to protect and restore cartilage. Clin. Orthop. Relat. Res. 379, S214\u2013S219 (2000).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"125_CR21","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/mt.2016.10","volume":"24","author":"ML Maeder","year":"2016","unstructured":"Maeder, M. L. & Gersbach, C. A. Genome-editing technologies for gene and cell therapy. Mol. Ther. 24, 430\u2013446 (2016).","journal-title":"Mol. Ther."},{"key":"125_CR22","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"125_CR23","first-page":"495","volume":"21","author":"M Cucchiarini","year":"2016","unstructured":"Cucchiarini, M. Human gene therapy: novel approaches to improve the current gene delivery systems. Discov. Med. 21, 495\u2013506 (2016).","journal-title":"Discov. Med."},{"key":"125_CR24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymthe.2005.03.012","volume":"12","author":"M Cucchiarini","year":"2005","unstructured":"Cucchiarini, M. et al. Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol. Ther 12, 229\u2013238 (2005).","journal-title":"Mol. Ther"},{"key":"125_CR25","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1089\/hum.2005.16.1413","volume":"16","author":"A Hiraide","year":"2005","unstructured":"Hiraide, A. et al. Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum. Gene Ther. 16, 1413\u20131421 (2005).","journal-title":"Hum. Gene Ther."},{"key":"125_CR26","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.joca.2011.05.007","volume":"19","author":"MI Menendez","year":"2011","unstructured":"Menendez, M. I. et al. Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. Osteoarthritis Cartilage 19, 1066\u20131075 (2011).","journal-title":"Osteoarthritis Cartilage"},{"key":"125_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/BLO.0b013e3180dca05f","volume":"462","author":"S Morisset","year":"2007","unstructured":"Morisset, S., Frisbie, D. D., Robbins, P. D., Nixon, A. J. & McIlwraith, C. W. IL-1ra\/IGF-1 gene therapy modulates repair of microfractured chondral defects. Clin. Orthop. Relat. Res. 462, 221\u2013228 (2007).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"125_CR28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.22203\/eCM.v018a09","volume":"18","author":"CH Evans","year":"2009","unstructured":"Evans, C. H. et al. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur. Cell. Mater. 18, 96\u2013111 (2009).","journal-title":"Eur. Cell. Mater."},{"key":"125_CR29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/gt.2010.16","volume":"17","author":"A Ivkovic","year":"2010","unstructured":"Ivkovic, A. et al. Articular cartilage repair by genetically modified bone marrow aspirate in sheep. Gene Ther. 17, 779\u2013789 (2010).","journal-title":"Gene Ther."},{"key":"125_CR30","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/art.30430","volume":"63","author":"TM Liu","year":"2011","unstructured":"Liu, T. M. et al. Zinc-finger protein 145, acting as an upstream regulator of SOX9, improves the differentiation potential of human mesenchymal stem cells for cartilage regeneration and repair. Arthritis Rheum. 63, 2711\u20132720 (2011).","journal-title":"Arthritis Rheum."},{"key":"125_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.joca.2014.11.008","volume":"23","author":"JT Sieker","year":"2015","unstructured":"Sieker, J. T. et al. Direct bone morphogenetic protein 2 and Indian hedgehog gene transfer for articular cartilage repair using bone marrow coagulates. Osteoarthritis Cartilage 23, 433\u2013442 (2015).","journal-title":"Osteoarthritis Cartilage"},{"key":"125_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/bies.950170310","volume":"17","author":"KI Berns","year":"1995","unstructured":"Berns, K. I. & Linden, R. M. The cryptic life style of adeno-associated virus. Bioessays 17, 237\u2013245 (1995).","journal-title":"Bioessays"},{"key":"125_CR33","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1073\/pnas.79.6.2077","volume":"79","author":"RJ Samulski","year":"1982","unstructured":"Samulski, R. J., Berns, K. I., Tan, M. & Muzyczka, N. Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc. Natl Acad. Sci. USA 79, 2077\u20132081 (1982).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR34","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00109-012-0978-9","volume":"91","author":"M Cucchiarini","year":"2013","unstructured":"Cucchiarini, M., Orth, P. & Madry, H. Direct rAAV SOX9 administration for durable articular cartilage repair with delayed terminal differentiation and hypertrophy in vivo. J. Mol. Med. 91, 625\u2013636 (2013).","journal-title":"J. Mol. Med."},{"key":"125_CR35","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.gt.3302515","volume":"12","author":"H Madry","year":"2005","unstructured":"Madry, H. et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther. 12, 1171\u20131179 (2005).","journal-title":"Gene Ther."},{"key":"125_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/hum.2008.075","volume":"20","author":"P Wehling","year":"2009","unstructured":"Wehling, P. et al. Clinical responses to gene therapy in joints of two subjects with rheumatoid arthritis. Hum. Gene Ther. 20, 97\u2013101 (2009).","journal-title":"Hum. Gene Ther."},{"key":"125_CR37","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","volume":"359","author":"CE Dunbar","year":"2018","unstructured":"Dunbar, C. E. et al. Gene therapy comes of age. Science 359, eaan4672 (2018).","journal-title":"Science"},{"key":"125_CR38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/humc.2017.249","volume":"29","author":"MK Kim","year":"2018","unstructured":"Kim, M. K. et al. A multicenter, double-blind, phase III clinical trial to evaluate the efficacy and safety of a cell and gene therapy in knee osteoarthritis patients. Hum. Gene Ther. Clin. Dev. 29, 48\u201359 (2018).","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"125_CR39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41584-018-0009-5","volume":"14","author":"CH Evans","year":"2018","unstructured":"Evans, C. H., Ghivizzani, S. C. & Robbins, P. D. Arthritis gene therapy is becoming a reality. Nat. Rev. Rheumatol. 14, 381\u2013382 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"125_CR40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/104303403321208998","volume":"14","author":"H Madry","year":"2003","unstructured":"Madry, H., Cucchiarini, M., Terwilliger, E. F. & Trippel, S. B. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum. Gene Ther. 14, 393\u2013402 (2003).","journal-title":"Hum. Gene Ther."},{"key":"125_CR41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ymthe.2005.08.004","volume":"13","author":"J Schuettrumpf","year":"2006","unstructured":"Schuettrumpf, J. et al. The inhibitory effects of anticoagulation on in vivo gene transfer by adeno-associated viral or adenoviral vectors. Mol. Ther 13, 88\u201397 (2006).","journal-title":"Mol. Ther"},{"key":"125_CR42","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.gt.3302591","volume":"12","author":"JL Anderson","year":"2005","unstructured":"Anderson, J. L. & Hope, T. J. Intracellular trafficking of retroviral vectors: obstacles and advances. Gene Ther. 12, 1667\u20131678 (2005).","journal-title":"Gene Ther."},{"key":"125_CR43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/187152612798995000","volume":"12","author":"DJ Glover","year":"2012","unstructured":"Glover, D. J. Artificial viruses: exploiting viral trafficking for therapeutics. Infect. Disord. Drug Targets 12, 68\u201380 (2012).","journal-title":"Infect. Disord. Drug Targets"},{"key":"125_CR44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gt.2010.31","volume":"17","author":"AP Lam","year":"2010","unstructured":"Lam, A. P. & Dean, D. A. Progress and prospects: nuclear import of nonviral vectors. Gene Ther. 17, 439\u2013447 (2010).","journal-title":"Gene Ther."},{"key":"125_CR45","volume":"16","author":"P Wu","year":"2018","unstructured":"Wu, P. et al. Non-viral gene delivery systems for tissue repair and regeneration. J. Transl Med. 16, 29 (2018).","journal-title":"J. Transl Med."},{"key":"125_CR46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/diseases6020042","volume":"6","author":"K Lundstrom","year":"2018","unstructured":"Lundstrom, K. Viral vectors in gene therapy. Diseases 6, 42 (2018).","journal-title":"Diseases"},{"key":"125_CR47","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","volume":"15","author":"MB Appaiahgari","year":"2015","unstructured":"Appaiahgari, M. B. & Vrati, S. Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls. Expert Opin. Biol. Ther. 15, 337\u2013351 (2015).","journal-title":"Expert Opin. Biol. Ther."},{"key":"125_CR48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.coviro.2016.08.007","volume":"21","author":"WF Goins","year":"2016","unstructured":"Goins, W. F., Hall, B., Cohen, J. B. & Glorioso, J. C. Retargeting of herpes simplex virus (HSV) vectors. Curr. Opin. Virol. 21, 93\u2013101 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"125_CR49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","volume":"25","author":"RG Crystal","year":"2014","unstructured":"Crystal, R. G. Adenovirus: the first effective in vivo gene delivery vector. Hum. Gene Ther. 25, 3\u201311 (2014).","journal-title":"Hum. Gene Ther."},{"key":"125_CR50","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1126\/science.286.5448.2244","volume":"286","author":"E Marshall","year":"1999","unstructured":"Marshall, E. Gene therapy death prompts review of adenovirus vector. Science 286, 2244\u20132245 (1999).","journal-title":"Science"},{"key":"125_CR51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","volume":"80","author":"SE Raper","year":"2003","unstructured":"Raper, S. E. et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148\u2013158 (2003).","journal-title":"Mol. Genet. Metab."},{"key":"125_CR52","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1089\/hum.2017.150","volume":"28","author":"C Vandamme","year":"2017","unstructured":"Vandamme, C., Adjali, O. & Mingozzi, F. Unraveling the complex story of immune responses to AAV vectors trial after trial. Hum. Gene Ther. 28, 1061\u20131074 (2017).","journal-title":"Hum. Gene Ther."},{"key":"125_CR53","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","volume":"84","author":"PL Felgner","year":"1987","unstructured":"Felgner, P. L. et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84, 7413\u20137417 (1987).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-800148-6.00001-8","volume":"88","author":"T Goodwin","year":"2014","unstructured":"Goodwin, T. & Huang, L. Nonviral vectors: we have come a long way. Adv. Genet. 88, 1\u201312 (2014).","journal-title":"Adv. Genet."},{"key":"125_CR55","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1089\/hum.2017.159","volume":"28","author":"M Schmeer","year":"2017","unstructured":"Schmeer, M., Buchholz, T. & Schleef, M. Plasmid DNA manufacturing for indirect and direct clinical applications. Hum. Gene Ther. 28, 856\u2013861 (2017).","journal-title":"Hum. Gene Ther."},{"key":"125_CR56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1358\/dnp.2007.20.4.1103528","volume":"20","author":"G Romano","year":"2007","unstructured":"Romano, G. Current development of nonviral-mediated gene transfer. Drug News Perspect. 20, 227\u2013231 (2007).","journal-title":"Drug News Perspect."},{"key":"125_CR57","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/JVI.74.3.1524-1532.2000","volume":"74","author":"CL Halbert","year":"2000","unstructured":"Halbert, C. L. et al. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74, 1524\u20131532 (2000).","journal-title":"J. Virol."},{"key":"125_CR58","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/gt.2008.55","volume":"15","author":"RH Smith","year":"2008","unstructured":"Smith, R. H. Adeno-associated virus integration: virus versus vector. Gene Ther. 15, 817\u2013822 (2008).","journal-title":"Gene Ther."},{"key":"125_CR59","doi-asserted-by":"crossref","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","volume":"90","author":"TR Flotte","year":"1993","unstructured":"Flotte, T. R. et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl Acad. Sci. USA 90, 10613\u201310617 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR60","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1165\/ajrcmb.11.5.7946381","volume":"11","author":"TR Flotte","year":"1994","unstructured":"Flotte, T. R., Afione, S. A. & Zeitlin, P. L. Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell. Mol. Biol. 11, 517\u2013521 (1994).","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"125_CR61","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2018.076","author":"R Ofri","year":"2018","unstructured":"Ofri, R. et al. Six years and counting: restoration of photopic retinal function and visual behavior following gene augmentation therapy in a sheep model of CNGA3 achromatopsia. Hum. Gene Ther. https:\/\/doi.org\/10.1089\/hum.2018.076 (2018).","journal-title":"Hum. Gene Ther."},{"key":"125_CR62","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1073\/pnas.97.12.6716","volume":"97","author":"Z Yan","year":"2000","unstructured":"Yan, Z., Zhang, Y., Duan, D. & Engelhardt, J. F. Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl Acad. Sci. USA 97, 6716\u20136721 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR63","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0014-5793(97)00311-6","volume":"407","author":"PL Hermonat","year":"1997","unstructured":"Hermonat, P. L., Quirk, J. G., Bishop, B. M. & Han, L. The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors. FEBS Lett. 407, 78\u201384 (1997).","journal-title":"FEBS Lett."},{"key":"125_CR64","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/75080","volume":"6","author":"D Duan","year":"2000","unstructured":"Duan, D., Yue, Y., Yan, Z. & Engelhardt, J. F. A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med. 6, 595\u2013598 (2000).","journal-title":"Nat. Med."},{"key":"125_CR65","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1128\/JVI.70.5.3227-3234.1996","volume":"70","author":"FK Ferrari","year":"1996","unstructured":"Ferrari, F. K., Samulski, T., Shenk, T. & Samulski, R. J. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227\u20133234 (1996).","journal-title":"J. Virol."},{"key":"125_CR66","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/JVI.70.1.520-532.1996","volume":"70","author":"KJ Fisher","year":"1996","unstructured":"Fisher, K. J. et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520\u2013532 (1996).","journal-title":"J. Virol."},{"key":"125_CR67","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty, D. M., Monahan, P. E. & Samulski, R. J. Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248\u20131254 (2001).","journal-title":"Gene Ther."},{"key":"125_CR68","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/hum.2006.17.440","volume":"17","author":"CL Halbert","year":"2006","unstructured":"Halbert, C. L. et al. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: implications for gene therapy using AAV vectors. Hum. Gene Ther. 17, 440\u2013447 (2006).","journal-title":"Hum. Gene Ther."},{"key":"125_CR69","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. Methods Clin. Dev. 8, 87\u2013104 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"125_CR70","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1023\/B:JOCI.0000019781.64421.5c","volume":"24","author":"V Cottard","year":"2004","unstructured":"Cottard, V. et al. Immune response against gene therapy vectors: influence of synovial fluid on adeno-associated virus mediated gene transfer to chondrocytes. J. Clin. Immunol. 24, 162\u2013169 (2004).","journal-title":"J. Clin. Immunol."},{"key":"125_CR71","doi-asserted-by":"crossref","first-page":"194ra92","DOI":"10.1126\/scitranslmed.3005795","volume":"5","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi, F. et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci. Transl Med. 5, 194ra92 (2013).","journal-title":"Sci. Transl Med."},{"key":"125_CR72","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","volume":"17","author":"S Nayak","year":"2010","unstructured":"Nayak, S. & Herzog, R. W. Progress and prospects: immune responses to viral vectors. Gene Ther. 17, 295\u2013304 (2010).","journal-title":"Gene Ther."},{"key":"125_CR73","first-page":"341","volume":"4","author":"R Calceo","year":"2013","unstructured":"Calceo, R. & Wilson, J. M. Humoral immune response to AAV. Front. Immunol. 4, 341 (2013).","journal-title":"Front. Immunol."},{"key":"125_CR74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molmed.2008.11.005","volume":"15","author":"TL Wu","year":"2009","unstructured":"Wu, T. L. & Ertl, H. C. Immune barriers to successful gene therapy. Trends Mol. Med. 15, 32\u201339 (2009).","journal-title":"Trends Mol. Med."},{"key":"125_CR75","first-page":"983","volume":"27","author":"J Goater","year":"2000","unstructured":"Goater, J. et al. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis. J. Rheumatol. 27, 983\u2013989 (2000).","journal-title":"J. Rheumatol."},{"key":"125_CR76","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/emmm.201202287","volume":"5","author":"KB Kaufmann","year":"2013","unstructured":"Kaufmann, K. B., Buning, H., Galy, A., Schambach, A. & Grez, M. Gene therapy on the move. EMBO Mol. Med. 5, 1642\u20131661 (2013).","journal-title":"EMBO Mol. Med."},{"key":"125_CR77","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1186\/ar745","volume":"5","author":"Z Mi","year":"2003","unstructured":"Mi, Z. et al. Adverse effects of adenovirus-mediated gene transfer of human transforming growth factor beta 1 into rabbit knees. Arthritis Res. Ther. 5, R132\u2013R139 (2003).","journal-title":"Arthritis Res. Ther."},{"key":"125_CR78","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","volume":"118","author":"S Hacein-Bey-Abina","year":"2008","unstructured":"Hacein-Bey-Abina, S. et al. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest. 118, 3132\u20133142 (2008).","journal-title":"J. Clin. Invest."},{"key":"125_CR79","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","volume":"118","author":"SJ Howe","year":"2008","unstructured":"Howe, S. J. et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118, 3143\u20133150 (2008).","journal-title":"J. Clin. Invest."},{"key":"125_CR80","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263\u2013267 (1996).","journal-title":"Science"},{"key":"125_CR81","doi-asserted-by":"crossref","first-page":"11395","DOI":"10.1073\/pnas.93.21.11395","volume":"93","author":"E Poeschla","year":"1996","unstructured":"Poeschla, E., Corbeau, P. & Wong-Staal, F. Development of HIV vectors for anti-HIV gene therapy. Proc. Natl Acad. Sci. USA 93, 11395\u201311399 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR82","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"JC Nault","year":"2015","unstructured":"Nault, J. C. et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat. Genet. 47, 1187\u20131193 (2015).","journal-title":"Nat. Genet."},{"key":"125_CR83","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/mt.2016.52","volume":"24","author":"I Gil-Farina","year":"2016","unstructured":"Gil-Farina, I. et al. Recombinant AAV integration is not associated with hepatic genotoxicity in nonhuman primates and patients. Mol. Ther. 24, 1100\u20131105 (2016).","journal-title":"Mol. Ther."},{"key":"125_CR84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1089\/hum.2016.147","volume":"28","author":"A Srivastava","year":"2017","unstructured":"Srivastava, A. & Carter, B. J. AAV infection: protection from cancer. Hum. Gene Ther. 28, 323\u2013327 (2017).","journal-title":"Hum. Gene Ther."},{"key":"125_CR85","unstructured":"Food and Drug Administration. Guidance for industry: preparation of IDEs and INDs for products intended to repair or replace knee cartilage. FDA.gov https:\/\/www.fda.gov\/downloads\/ucm288011.pdf (2011)."},{"key":"125_CR86","unstructured":"European Commission. Good manufacturing practice for advanced therapy medicinal products. ec.europa.eu https:\/\/ec.europa.eu\/health\/sites\/health\/files\/files\/eudralex\/vol-4\/2017_11_22_guidelines_gmp_for_atmps.pdf (2017)."},{"key":"125_CR87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1063-4584(97)80023-4","volume":"5","author":"VM Baragi","year":"1997","unstructured":"Baragi, V. M. et al. Transplantation of adenovirally transduced allogeneic chondrocytes into articular cartilage defects in vivo. Osteoarthritis Cartilage 5, 275\u2013282 (1997).","journal-title":"Osteoarthritis Cartilage"},{"key":"125_CR88","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.gt.3301086","volume":"7","author":"H Madry","year":"2000","unstructured":"Madry, H. & Trippel, S. B. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 7, 286\u2013291 (2000).","journal-title":"Gene Ther."},{"key":"125_CR89","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/gt.2014.90","volume":"22","author":"A Rey-Rico","year":"2015","unstructured":"Rey-Rico, A. et al. Determination of effective rAAV-mediated gene transfer conditions to support chondrogenic differentiation processes in human primary bone marrow aspirates. Gene Ther. 22, 50\u201357 (2015).","journal-title":"Gene Ther."},{"key":"125_CR90","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1128\/JVI.72.12.9795-9805.1998","volume":"72","author":"CL Halbert","year":"1998","unstructured":"Halbert, C. L., Standaert, T. A., Wilson, C. B. & Miller, A. D. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J. Virol. 72, 9795\u20139805 (1998).","journal-title":"J. Virol."},{"key":"125_CR91","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.2174\/1389201015666140327141710","volume":"14","author":"RS Selot","year":"2014","unstructured":"Selot, R. S., Hareendran, S. & Jayandharan, G. R. Developing immunologically inert adeno-associated virus (AAV) vectors for gene therapy: possibilities and limitations. Curr. Pharm. Biotechnol. 14, 1072\u20131082 (2014).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"125_CR92","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.tibtech.2015.09.008","volume":"33","author":"CJ Buchholz","year":"2015","unstructured":"Buchholz, C. J., Friedel, T. & Buning, H. Surface-engineered viral vectors for selective and cell type-specific gene delivery. Trends Biotechnol. 33, 777\u2013790 (2015).","journal-title":"Trends Biotechnol."},{"key":"125_CR93","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.coph.2015.08.002","volume":"24","author":"H Buning","year":"2015","unstructured":"Buning, H., Huber, A., Zhang, L., Meumann, N. & Hacker, U. Engineering the AAV capsid to optimize vector-host-interactions. Curr. Opin. Pharmacol. 24, 94\u2013104 (2015).","journal-title":"Curr. Opin. Pharmacol."},{"key":"125_CR94","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","volume":"122","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi, F. & High, K. A. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122, 23\u201336 (2013).","journal-title":"Blood"},{"key":"125_CR95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/156652310793180706","volume":"10","author":"AM Mitchell","year":"2010","unstructured":"Mitchell, A. M., Nicolson, S. C., Warischalk, J. K. & Samulski, R. J. AAV\u2019s anatomy: roadmap for optimizing vectors for translational success. Curr. Gene Ther. 10, 319\u2013340 (2010).","journal-title":"Curr. Gene Ther."},{"key":"125_CR96","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/gt.2008.170","volume":"16","author":"LH Vandenberghe","year":"2009","unstructured":"Vandenberghe, L. H., Wilson, J. M. & Gao, G. Tailoring the AAV vector capsid for gene therapy. Gene Ther. 16, 311\u2013319 (2009).","journal-title":"Gene Ther."},{"key":"125_CR97","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/00003086-199910001-00006","volume":"367","author":"LE Freed","year":"1999","unstructured":"Freed, L. E., Martin, I. & Vunjak-Novakovic, G. Frontiers in tissue engineering. In vitro modulation of chondrogenesis. Clin. Orthop. Relat. Res. 367, S46\u2013S58 (1999).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"125_CR98","volume":"1","author":"E Kon","year":"2014","unstructured":"Kon, E., Filardo, G., Perdisa, F., Venieri, G. & Marcacci, M. Clinical results of multilayered biomaterials for osteochondral regeneration. J. Exp. Orthop. 1, 10 (2014).","journal-title":"J. Exp. Orthop."},{"key":"125_CR99","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.arthro.2014.11.017","volume":"31","author":"E Kon","year":"2015","unstructured":"Kon, E., Roffi, A., Filardo, G., Tesei, G. & Marcacci, M. Scaffold-based cartilage treatments: with or without cells? A systematic review of preclinical and clinical evidence. Arthroscopy 31, 767\u2013775 (2015).","journal-title":"Arthroscopy"},{"key":"125_CR100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2017.11.021","volume":"65","author":"AR Armiento","year":"2018","unstructured":"Armiento, A. R., Stoddart, M. J., Alini, M. & Eglin, D. Biomaterials for articular cartilage tissue engineering: learning from biology. Acta Biomater. 65, 1\u201320 (2018).","journal-title":"Acta Biomater."},{"key":"125_CR101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.22203\/eCM.v027sa03","volume":"27","author":"M Cucchiarini","year":"2014","unstructured":"Cucchiarini, M. et al. A vision on the future of articular cartilage repair. Eur. Cell. Mater. 27, 12\u201316 (2014).","journal-title":"Eur. Cell. Mater."},{"key":"125_CR102","doi-asserted-by":"crossref","first-page":"248","DOI":"10.22203\/eCM.v025a18","volume":"25","author":"B Johnstone","year":"2013","unstructured":"Johnstone, B. et al. Tissue engineering for articular cartilage repair \u2014 the state of the art. Eur. Cell. Mater. 25, 248\u2013267 (2013).","journal-title":"Eur. Cell. Mater."},{"key":"125_CR103","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1089\/ten.tea.2013.0356","volume":"20","author":"S Lopa","year":"2014","unstructured":"Lopa, S. & Madry, H. Bioinspired scaffolds for osteochondral regeneration. Tissue Eng. Part A 20, 2052\u20132076 (2014).","journal-title":"Tissue Eng. Part A."},{"key":"125_CR104","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biotechadv.2012.11.004","volume":"31","author":"SP Nukavarapu","year":"2013","unstructured":"Nukavarapu, S. P. & Dorcemus, D. L. Osteochondral tissue engineering: current strategies and challenges. Biotechnol. Adv. 31, 706\u2013721 (2013).","journal-title":"Biotechnol. Adv."},{"key":"125_CR105","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrrheum.2015.27","volume":"11","author":"BD Smith","year":"2015","unstructured":"Smith, B. D. & Grande, D. A. The current state of scaffolds for musculoskeletal regenerative applications. Nat. Rev. Rheumatol. 11, 213\u2013222 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"125_CR106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.copbio.2016.02.009","volume":"40","author":"MA Serban","year":"2016","unstructured":"Serban, M. A. Translational biomaterials-the journey from the bench to the market-think \u2018product\u2019. Curr. Opin. Biotechnol. 40, 31\u201334 (2016).","journal-title":"Curr. Opin. Biotechnol."},{"key":"125_CR107","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0363546509346395","volume":"38","author":"M Brittberg","year":"2010","unstructured":"Brittberg, M. Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am. J. Sports Med. 38, 1259\u20131271 (2010).","journal-title":"Am. J. Sports Med."},{"key":"125_CR108","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0142-9612(96)85754-1","volume":"17","author":"KA Athanasiou","year":"1996","unstructured":"Athanasiou, K. A., Niederauer, G. G. & Agrawal, C. M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid\/polyglycolic acid copolymers. Biomaterials 17, 93\u2013102 (1996).","journal-title":"Biomaterials"},{"key":"125_CR109","doi-asserted-by":"crossref","first-page":"229","DOI":"10.22203\/eCM.v025a17","volume":"25","author":"H Madry","year":"2013","unstructured":"Madry, H., Kaul, G., Zurakowski, D., Vunjak-Novakovic, G. & Cucchiarini, M. Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model. Eur. Cell. Mater. 25, 229\u2013247 (2013).","journal-title":"Eur. Cell. Mater."},{"key":"125_CR110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.csm.2017.02.008","volume":"36","author":"BB Hinckel","year":"2017","unstructured":"Hinckel, B. B. & Gomoll, A. H. Autologous chondrocytes and next-generation matrix-based autologous chondrocyte implantation. Clin. Sports Med. 36, 525\u2013548 (2017).","journal-title":"Clin. Sports Med."},{"key":"125_CR111","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/17434440.2017.1368386","volume":"14","author":"L Gao","year":"2017","unstructured":"Gao, L., Orth, P., Cucchiarini, M. & Madry, H. Effects of solid acellular type-I\/III collagen biomaterials on in vitro and in vivo chondrogenesis of mesenchymal stem cells. Expert Rev. Med. Devices 14, 717\u2013732 (2017).","journal-title":"Expert Rev. Med. Devices"},{"key":"125_CR112","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0092-8674(82)90027-7","volume":"30","author":"PD Benya","year":"1982","unstructured":"Benya, P. D. & Shaffer, J. D. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell 30, 215\u2013224 (1982).","journal-title":"Cell"},{"key":"125_CR113","doi-asserted-by":"crossref","first-page":"59","DOI":"10.22203\/eCM.v033a05","volume":"33","author":"SL Vega","year":"2017","unstructured":"Vega, S. L., Kwon, M. Y. & Burdick, J. A. Recent advances in hydrogels for cartilage tissue engineering. Eur. Cell. Mater. 33, 59\u201375 (2017).","journal-title":"Eur. Cell. Mater."},{"key":"125_CR114","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.arthro.2012.05.891","volume":"29","author":"G Filardo","year":"2013","unstructured":"Filardo, G., Kon, E., Roffi, A., Di Martino, A. & Marcacci, M. Scaffold-based repair for cartilage healing: a systematic review and technical note. Arthroscopy 29, 174\u2013186 (2013).","journal-title":"Arthroscopy"},{"key":"125_CR115","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1016\/S0142-9612(03)00160-1","volume":"24","author":"D Girotto","year":"2003","unstructured":"Girotto, D. et al. Tissue-specific gene expression in chondrocytes grown on three-dimensional hyaluronic acid scaffolds. Biomaterials 24, 3265\u20133275 (2003).","journal-title":"Biomaterials"},{"key":"125_CR116","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biomaterials.2016.02.023","volume":"89","author":"AK Jha","year":"2016","unstructured":"Jha, A. K. et al. Matrix metalloproteinase-13 mediated degradation of hyaluronic acid-based matrices orchestrates stem cell engraftment through vascular integration. Biomaterials 89, 136\u2013147 (2016).","journal-title":"Biomaterials"},{"key":"125_CR117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.csm.2016.02.001","volume":"35","author":"A Kandil","year":"2016","unstructured":"Kandil, A. & Safran, M. R. Hip arthroscopy: a brief history. Clin. Sports Med. 35, 321\u2013329 (2016).","journal-title":"Clin. Sports Med."},{"key":"125_CR118","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/jbm.b.32981","volume":"101","author":"D Seol","year":"2013","unstructured":"Seol, D. et al. Biocompatibility and preclinical feasibility tests of a temperature-sensitive hydrogel for the purpose of surgical wound pain control and cartilage repair. J. Biomed. Mater. Res. B Appl. Biomater. 101, 1508\u20131515 (2013).","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"125_CR119","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actbio.2015.08.038","volume":"27","author":"M Bartnikowski","year":"2015","unstructured":"Bartnikowski, M., Bartnikowski, N. J., Woodruff, M. A., Schrobback, K. & Klein, T. J. Protective effects of reactive functional groups on chondrocytes in photocrosslinkable hydrogel systems. Acta Biomater. 27, 66\u201376 (2015).","journal-title":"Acta Biomater."},{"key":"125_CR120","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1177\/0363546509335463","volume":"37","author":"KF Almqvist","year":"2009","unstructured":"Almqvist, K. F. et al. Treatment of cartilage defects in the knee using alginate beads containing human mature allogenic chondrocytes. Am. J. Sports Med. 37, 1920\u20131929 (2009).","journal-title":"Am. J. Sports Med."},{"key":"125_CR121","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1177\/0363546515599632","volume":"43","author":"YS Kim","year":"2015","unstructured":"Kim, Y. S. et al. Comparative matched-pair analysis of the injection versus implantation of mesenchymal stem cells for knee osteoarthritis. Am. J. Sports Med. 43, 2738\u20132746 (2015).","journal-title":"Am. J. Sports Med."},{"key":"125_CR122","doi-asserted-by":"publisher","DOI":"10.1007\/s00167-018-5079-z","author":"H Sofu","year":"2018","unstructured":"Sofu, H. et al. Clinical and radiographic outcomes of chitosan-glycerol phosphate\/blood implant are similar with hyaluronic acid-based cell-free scaffold in the treatment of focal osteochondral lesions of the knee joint. Knee Surg. Sports Traumatol. Arthrosc. https:\/\/doi.org\/10.1007\/s00167-018-5079-z (2018).","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"125_CR123","doi-asserted-by":"crossref","first-page":"442","DOI":"10.5301\/hipint.5000580","volume":"28","author":"S Thier","year":"2017","unstructured":"Thier, S., Baumann, F., Weiss, C. & Fickert, S. Feasibility of arthroscopic autologous chondrocyte implantation in the hip using an injectable hydrogel. Hip. Int. 28, 442\u2013449 (2017).","journal-title":"Hip. Int."},{"key":"125_CR124","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1097\/00003086-200010001-00023","volume":"379","author":"JM Mason","year":"2000","unstructured":"Mason, J. M. et al. Cartilage and bone regeneration using gene-enhanced tissue engineering. Clin. Orthop. Relat. Res. 379, S171\u2013S178 (2000).","journal-title":"Clin. Orthop. Relat. Res."},{"key":"125_CR125","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1302\/0301-620X.89B5.18343","volume":"89","author":"LR Goodrich","year":"2007","unstructured":"Goodrich, L. R., Hidaka, C., Robbins, P. D., Evans, C. H. & Nixon, A. J. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J. Bone Joint Surg. Br. 89, 672\u2013685 (2007).","journal-title":"J. Bone Joint Surg. Br."},{"key":"125_CR126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2106\/00004623-200300002-00015","volume":"85-A","author":"DA Grande","year":"2003","unstructured":"Grande, D. A., Mason, J., Light, E. & Dines, D. Stem cells as platforms for delivery of genes to enhance cartilage repair. J. Bone Joint Surg. Am. 85-A, 111\u2013116 (2003).","journal-title":"J. Bone Joint Surg. Am."},{"key":"125_CR127","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1016\/j.biomaterials.2011.02.014","volume":"32","author":"L Cao","year":"2011","unstructured":"Cao, L. et al. The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials 32, 3910\u20133920 (2011).","journal-title":"Biomaterials"},{"key":"125_CR128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.addr.2014.06.006","volume":"84","author":"J Lam","year":"2015","unstructured":"Lam, J., Lu, S., Kasper, F. K. & Mikos, A. G. Strategies for controlled delivery of biologics for cartilage repair. Adv. Drug Deliv. Rev. 84, 123\u2013134 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"125_CR129","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3349\/ymj.2000.41.6.704","volume":"41","author":"SJ Lee","year":"2000","unstructured":"Lee, S. J. Cytokine delivery and tissue engineering. Yonsei Med. J. 41, 704\u2013719 (2000).","journal-title":"Yonsei Med. J."},{"key":"125_CR130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ymthe.2004.03.020","volume":"10","author":"AK Pannier","year":"2004","unstructured":"Pannier, A. K. & Shea, L. D. Controlled release systems for DNA delivery. Mol. Ther. 10, 19\u201326 (2004).","journal-title":"Mol. Ther."},{"key":"125_CR131","doi-asserted-by":"crossref","first-page":"20600","DOI":"10.1021\/acsami.6b06509","volume":"8","author":"A Rey-Rico","year":"2016","unstructured":"Rey-Rico, A. et al. PEO-PPO-PEO carriers for rAAV-mediated transduction of human articular chondrocytes in vitro and in a human osteochondral defect model. ACS Appl. Mater. Interfaces 8, 20600\u201320613 (2016).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"125_CR132","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00441-011-1197-3","volume":"347","author":"KM Dupont","year":"2012","unstructured":"Dupont, K. M. et al. Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res. 347, 575\u2013588 (2012).","journal-title":"Cell Tissue Res."},{"key":"125_CR133","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1073\/pnas.93.12.5753","volume":"93","author":"J Fang","year":"1996","unstructured":"Fang, J. et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc. Natl Acad. Sci. USA 93, 5753\u20135758 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR134","doi-asserted-by":"crossref","first-page":"E798","DOI":"10.1073\/pnas.1321744111","volume":"111","author":"JM Brunger","year":"2014","unstructured":"Brunger, J. M. et al. Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage. Proc. Natl Acad. Sci. USA 111, E798\u2013E806 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR135","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1016\/j.biomaterials.2014.03.073","volume":"35","author":"KA Glass","year":"2014","unstructured":"Glass, K. A. et al. Tissue-engineered cartilage with inducible and tunable immunomodulatory properties. Biomaterials 35, 5921\u20135931 (2014).","journal-title":"Biomaterials"},{"key":"125_CR136","doi-asserted-by":"crossref","first-page":"E4513","DOI":"10.1073\/pnas.1601639113","volume":"113","author":"FT Moutos","year":"2016","unstructured":"Moutos, F. T. et al. Anatomically shaped tissue-engineered cartilage with tunable and inducible anticytokine delivery for biological joint resurfacing. Proc. Natl Acad. Sci. USA 113, E4513\u2013E4522 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR137","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.ijpharm.2015.11.008","volume":"496","author":"P Diaz-Rodriguez","year":"2015","unstructured":"Diaz-Rodriguez, P., Rey-Rico, A., Madry, H., Landin, M. & Cucchiarini, M. Effective genetic modification and differentiation of hMSCs upon controlled release of rAAV vectors using alginate\/poloxamer composite systems. Int. J. Pharm. 496, 614\u2013626 (2015).","journal-title":"Int. J. Pharm."},{"key":"125_CR138","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1089\/ten.tea.2010.0586","volume":"17","author":"HH Lee","year":"2011","unstructured":"Lee, H. H. et al. Release of bioactive adeno-associated virus from fibrin scaffolds: effects of fibrin glue concentrations. Tissue Eng. Part A 17, 1969\u20131978 (2011).","journal-title":"Tissue Eng. Part A."},{"key":"125_CR139","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.actbio.2015.02.013","volume":"18","author":"A Rey-Rico","year":"2015","unstructured":"Rey-Rico, A. et al. Effective and durable genetic modification of human mesenchymal stem cells via controlled release of rAAV vectors from self-assembling peptide hydrogels with a maintained differentiation potency. Acta Biomater. 18, 118\u2013127 (2015).","journal-title":"Acta Biomater."},{"key":"125_CR140","doi-asserted-by":"crossref","first-page":"6985","DOI":"10.2147\/IJN.S144579","volume":"12","author":"A Rey-Rico","year":"2017","unstructured":"Rey-Rico, A. et al. rAAV-mediated overexpression of TGF-beta via vector delivery in polymeric micelles stimulates the biological and reparative activities of human articular chondrocytes in vitro and in a human osteochondral defect model. Int. J. Nanomed. 12, 6985\u20136996 (2017).","journal-title":"Int. J. Nanomed."},{"key":"125_CR141","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.actbio.2015.08.046","volume":"27","author":"A Rey-Rico","year":"2015","unstructured":"Rey-Rico, A. et al. PEO-PPO-PEO micelles as effective rAAV-mediated gene delivery systems to target human mesenchymal stem cells without altering their differentiation potency. Acta Biomater. 27, 42\u201352 (2015).","journal-title":"Acta Biomater."},{"key":"125_CR142","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijpharm.2017.05.050","volume":"531","author":"A Rey-Rico","year":"2017","unstructured":"Rey-Rico, A. et al. Supramolecular polypseudorotaxane gels for controlled delivery of rAAV vectors in human mesenchymal stem cells for regenerative medicine. Int. J. Pharm. 531, 492\u2013503 (2017).","journal-title":"Int. J. Pharm."},{"key":"125_CR143","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.97.2.811","volume":"97","author":"M Singh","year":"2000","unstructured":"Singh, M. et al. Cationic microparticles: a potent delivery system for DNA vaccines. Proc. Natl Acad. Sci. USA 97, 811\u2013816 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR144","volume":"9","author":"R Zhao","year":"2014","unstructured":"Zhao, R., Peng, X., Li, Q. & Song, W. Effects of phosphorylatable short peptide-conjugated chitosan-mediated IL-1Ra and IGF-1 gene transfer on articular cartilage defects in rabbits. PLoS ONE 9, e112284 (2014).","journal-title":"PLoS ONE"},{"key":"125_CR145","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/jbm.a.34618","volume":"101","author":"B Li","year":"2013","unstructured":"Li, B. et al. Fabrication of poly(lactide-co-glycolide) scaffold filled with fibrin gel, mesenchymal stem cells, and poly(ethylene oxide)-b-poly(L-lysine)\/TGF-beta1 plasmid DNA complexes for cartilage restoration in vivo. J. Biomed. Mater. Res. A 101, 3097\u20133108 (2013).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"125_CR146","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1021\/mp5000136","volume":"11","author":"B Li","year":"2014","unstructured":"Li, B. et al. Poly(lactide-co-glycolide)\/fibrin gel construct as a 3D model to evaluate gene therapy of cartilage in vivo. Mol. Pharm 11, 2062\u20132070 (2014).","journal-title":"Mol. Pharm"},{"key":"125_CR147","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1016\/j.biomaterials.2010.04.029","volume":"31","author":"W Wang","year":"2010","unstructured":"Wang, W. et al. In vivo restoration of full-thickness cartilage defects by poly(lactide-co-glycolide) sponges filled with fibrin gel, bone marrow mesenchymal stem cells and DNA complexes. Biomaterials 31, 5953\u20135965 (2010).","journal-title":"Biomaterials"},{"key":"125_CR148","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.joca.2017.05.003","volume":"25","author":"D Almarza","year":"2017","unstructured":"Almarza, D., Cucchiarini, M. & Loughlin, J. Genome editing for human osteoarthritis - a perspective. Osteoarthritis Cartilage 25, 1195\u20131198 (2017).","journal-title":"Genome editing for human osteoarthritis - a perspective. Osteoarthritis Cartilage"},{"key":"125_CR149","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/art.39982","volume":"69","author":"JM Brunger","year":"2017","unstructured":"Brunger, J. M., Zutshi, A., Willard, V. P., Gersbach, C. A. & Guilak, F. CRISPR\/Cas9 editing of murine induced pluripotent stem cells for engineering inflammation-resistant tissues. Arthritis Rheumatol. 69, 1111\u20131121 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"125_CR150","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.stemcr.2017.03.022","volume":"8","author":"JM Brunger","year":"2017","unstructured":"Brunger, J. M., Zutshi, A., Willard, V. P., Gersbach, C. A. & Guilak, F. Genome engineering of stem cells for autonomously regulated, closed-loop delivery of biologic drugs. Stem Cell Rep. 8, 1202\u20131213 (2017).","journal-title":"Stem Cell Rep."},{"key":"125_CR151","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1089\/ten.tea.2016.0441","volume":"23","author":"N Farhang","year":"2017","unstructured":"Farhang, N. et al. CRISPR-based epigenome editing of cytokine receptors for the promotion of cell survival and tissue deposition in inflammatory environments. Tissue Eng. Part A 23, 738\u2013749 (2017).","journal-title":"Tissue Eng. Part A."},{"key":"125_CR152","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrrheum.2016.219","volume":"13","author":"PM Kraan van der","year":"2017","unstructured":"van der Kraan, P. M. The changing role of TGF\u03b2 in healthy, ageing and osteoarthritic joints. Nat. Rev. Rheumatol. 13, 155\u2013163 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"125_CR153","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1517\/14712598.2016.1124084","volume":"16","author":"H Madry","year":"2016","unstructured":"Madry, H. & Cucchiarini, M. Gene therapy for human osteoarthritis: principles and clinical translation. Expert Opin. Biol. Ther. 16, 331\u2013346 (2016).","journal-title":"Expert Opin. Biol. Ther."},{"key":"125_CR154","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.2106\/JBJS.16.00603","volume":"99","author":"AJ Nixon","year":"2017","unstructured":"Nixon, A. J. et al. Matrix-induced autologous chondrocyte implantation (MACI) using a cell-seeded collagen membrane improves cartilage healing in the equine model. J. Bone Joint Surg. Am. 99, 1987\u20131998 (2017).","journal-title":"J. Bone Joint Surg. Am."},{"key":"125_CR155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cytogfr.2015.11.006","volume":"27","author":"K Schmidt-Bleek","year":"2016","unstructured":"Schmidt-Bleek, K., Willie, B. M., Schwabe, P., Seemann, P. & Duda, G. N. BMPs in bone regeneration: less is more effective, a paradigm-shift. Cytokine Growth Factor Rev. 27, 141\u2013148 (2016).","journal-title":"Cytokine Growth Factor Rev."},{"key":"125_CR156","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0006-291X(88)90579-7","volume":"151","author":"MA Eglitis","year":"1988","unstructured":"Eglitis, M. A., Kohn, D. B., Moen, R. C., Blaese, R. M. & Anderson, W. F. Infection of human hematopoietic progenitor cells using a retroviral vector with a xenotropic pseudotype. Biochem. Biophys. Res. Commun. 151, 201\u2013206 (1988).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"125_CR157","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1073\/pnas.80.15.4709","volume":"80","author":"AD Miller","year":"1983","unstructured":"Miller, A. D., Jolly, D. J., Friedmann, T. & Verma, I. M. A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT. Proc. Natl Acad. Sci. USA 80, 4709\u20134713 (1983).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"125_CR158","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1128\/JVI.70.11.8098-8108.1996","volume":"70","author":"X Xiao","year":"1996","unstructured":"Xiao, X., Li, J. & Samulski, R. J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098\u20138108 (1996).","journal-title":"J. Virol."},{"key":"125_CR159","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/gt.2014.58","volume":"21","author":"M Cucchiarini","year":"2014","unstructured":"Cucchiarini, M. & Madry, H. Overexpression of human IGF-I via direct rAAV-mediated gene transfer improves the early repair of articular cartilage defects in vivo. Gene Ther. 21, 811\u2013819 (2014).","journal-title":"Gene Ther."},{"key":"125_CR160","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.gt.3302938","volume":"14","author":"MR Pagnotto","year":"2007","unstructured":"Pagnotto, M. R. et al. Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair. Gene Ther. 14, 804\u2013813 (2007).","journal-title":"Gene Ther."},{"key":"125_CR161","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jgm.826","volume":"8","author":"J Park","year":"2006","unstructured":"Park, J. et al. Transgene-activated mesenchymal cells for articular cartilage repair: a comparison of primary bone marrow-, perichondrium\/periosteum- and fat-derived cells. J. Gene Med. 8, 112\u2013125 (2006).","journal-title":"J. Gene Med."},{"key":"125_CR162","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.24153","volume":"60","author":"S Kubo","year":"2009","unstructured":"Kubo, S. et al. Blocking vascular endothelial growth factor with soluble Flt-1 improves the chondrogenic potential of mouse skeletal muscle-derived stem cells. Arthritis Rheum. 60, 155\u2013165 (2009).","journal-title":"Arthritis Rheum."},{"key":"125_CR163","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1002\/art.24125","volume":"58","author":"T Matsumoto","year":"2008","unstructured":"Matsumoto, T. et al. The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum. 58, 3809\u20133819 (2008).","journal-title":"Arthritis Rheum."},{"key":"125_CR164","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/art.10759","volume":"48","author":"K Gelse","year":"2003","unstructured":"Gelse, K., von der Mark, K., Aigner, T., Park, J. & Schneider, H. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum. 48, 430\u2013441 (2003).","journal-title":"Arthritis Rheum."},{"key":"125_CR165","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00167-009-0962-2","volume":"18","author":"JH Che","year":"2010","unstructured":"Che, J. H. et al. Application of tissue-engineered cartilage with BMP-7 gene to repair knee joint cartilage injury in rabbits. Knee Surg. Sports Traumatol. Arthrosc. 18, 496\u2013503 (2010).","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"125_CR166","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/jgm.819","volume":"8","author":"G Kaul","year":"2006","unstructured":"Kaul, G. et al. Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. J. Gene Med. 8, 100\u2013111 (2006).","journal-title":"J. Gene Med."},{"key":"125_CR167","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1007\/s00167-011-1448-6","volume":"19","author":"P Orth","year":"2011","unstructured":"Orth, P. et al. Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo. Knee Surg. Sports Traumatol. Arthrosc. 19, 2119\u20132130 (2011).","journal-title":"Knee Surg. Sports Traumatol. Arthrosc."},{"key":"125_CR168","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/art.20739","volume":"52","author":"N Yokoo","year":"2005","unstructured":"Yokoo, N. et al. Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector. Arthritis Rheum. 52, 164\u2013170 (2005).","journal-title":"Arthritis Rheum."},{"key":"125_CR169","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3892\/etm.2016.3972","volume":"13","author":"X Xia","year":"2017","unstructured":"Xia, X. et al. Matrigel scaffold combined with Ad-hBMP7-transfected chondrocytes improves the repair of rabbit cartilage defect. Exp. Ther. Med. 13, 542\u2013550 (2017).","journal-title":"Exp. Ther. Med."},{"key":"125_CR170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1258\/ebm.2012.012223","volume":"238","author":"BW Qi","year":"2013","unstructured":"Qi, B. W., Yu, A. X., Zhu, S. B., Zhou, M. & Wu, G. Chitosan\/poly(vinyl alcohol) hydrogel combined with Ad-hTGF-beta1 transfected mesenchymal stem cells to repair rabbit articular cartilage defects. Exp. Biol. Med. 238, 23\u201330 (2013).","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"125_CR171","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3727\/096368913X669770","volume":"23","author":"S Zhu","year":"2014","unstructured":"Zhu, S. et al. Combined effects of connective tissue growth factor-modified bone marrow-derived mesenchymal stem cells and NaOH-treated PLGA scaffolds on the repair of articular cartilage defect in rabbits. Cell Transplant. 23, 715\u2013727 (2014).","journal-title":"Cell Transplant."},{"key":"125_CR172","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/term.212","volume":"4","author":"B Hu","year":"2010","unstructured":"Hu, B. et al. Enhanced treatment of articular cartilage defect of the knee by intra-articular injection of Bcl-xL-engineered mesenchymal stem cells in rabbit model. J. Tissue Eng. Regen. Med. 4, 105\u2013114 (2010).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"125_CR173","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/rheumatology\/keh240","volume":"43","author":"R Katayama","year":"2004","unstructured":"Katayama, R. et al. Repair of articular cartilage defects in rabbits using CDMP1 gene-transfected autologous mesenchymal cells derived from bone marrow. Rheumatology 43, 980\u2013985 (2004).","journal-title":"Rheumatology"},{"key":"125_CR174","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1088\/1748-6041\/1\/4\/006","volume":"1","author":"X Guo","year":"2006","unstructured":"Guo, X. et al. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene. Biomed. Mater. 1, 206\u2013215 (2006).","journal-title":"Biomed. Mater."},{"key":"125_CR175","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.arthro.2013.09.076","volume":"29","author":"J Shi","year":"2013","unstructured":"Shi, J. et al. Nanoparticle delivery of the bone morphogenetic protein 4 gene to adipose-derived stem cells promotes articular cartilage repair in vitro and in vivo. Arthroscopy 29, 2001\u20132011 (2013).","journal-title":"Arthroscopy"},{"key":"125_CR176","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.joca.2008.04.006","volume":"16","author":"K Gelse","year":"2008","unstructured":"Gelse, K. et al. Chondrogenic differentiation of growth factor-stimulated precursor cells in cartilage repair tissue is associated with increased HIF-1alpha activity. Osteoarthritis Cartilage 16, 1457\u20131465 (2008).","journal-title":"Osteoarthritis Cartilage"},{"key":"125_CR177","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0736-0266(02)00264-4","volume":"21","author":"C Hidaka","year":"2003","unstructured":"Hidaka, C. et al. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J. Orthop. Res. 21, 573\u2013583 (2003).","journal-title":"J. Orthop. Res."},{"key":"125_CR178","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/jor.23038","volume":"34","author":"DJ Griffin","year":"2016","unstructured":"Griffin, D. J., Ortved, K. F., Nixon, A. J. & Bonassar, L. J. Mechanical properties and structure-function relationships in articular cartilage repaired using IGF-I gene-enhanced chondrocytes. J. Orthop. Res. 34, 149\u2013153 (2016).","journal-title":"J. Orthop. Res."},{"key":"125_CR179","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/mt.2014.198","volume":"23","author":"KF Ortved","year":"2015","unstructured":"Ortved, K. F., Begum, L., Mohammed, H. O. & Nixon, A. J. Implantation of rAAV5-IGF-I transduced autologous chondrocytes improves cartilage repair in full-thickness defects in the equine model. Mol. Ther. 23, 363\u2013373 (2015).","journal-title":"Mol. Ther."},{"key":"125_CR180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1089\/107632701753337708","volume":"7","author":"C Andree","year":"2001","unstructured":"Andree, C. et al. Plasmid gene delivery to human keratinocytes through a fibrin-mediated transfection system. Tissue Eng. 7, 757\u2013766 (2001).","journal-title":"Tissue Eng."},{"key":"125_CR181","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0142-9612(99)00229-X","volume":"21","author":"AU Bielinska","year":"2000","unstructured":"Bielinska, A. U. et al. Application of membrane-based dendrimer\/DNA complexes for solid phase transfection in vitro and in vivo. Biomaterials 21, 877\u2013887 (2000).","journal-title":"Biomaterials"},{"key":"125_CR182","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0736-0266(02)00153-5","volume":"21","author":"CR Lee","year":"2003","unstructured":"Lee, C. R., Grodzinsky, A. J., Hsu, H. P. & Spector, M. Effects of a cultured autologous chondrocyte-seeded type II collagen scaffold on the healing of a chondral defect in a canine model. J. Orthop. Res. 21, 272\u2013281 (2003).","journal-title":"J. Orthop. Res."},{"key":"125_CR183","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1023\/A:1023887203111","volume":"20","author":"Z Li","year":"2003","unstructured":"Li, Z. et al. Controlled gene delivery system based on thermosensitive biodegradable hydrogel. Pharm. Res. 20, 884\u2013888 (2003).","journal-title":"Pharm. Res."},{"key":"125_CR184","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/mt.2009.300","volume":"18","author":"S Shin","year":"2010","unstructured":"Shin, S. & Shea, L. D. Lentivirus immobilization to nanoparticles for enhanced and localized delivery from hydrogels. Mol. Ther. 18, 700\u2013706 (2010).","journal-title":"Mol. Ther."},{"key":"125_CR185","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/j.biomaterials.2010.02.013","volume":"31","author":"S Shin","year":"2010","unstructured":"Shin, S., Tuinstra, H. M., Salvay, D. M. & Shea, L. D. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 31, 4353\u20134359 (2010).","journal-title":"Biomaterials"},{"key":"125_CR186","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jconrel.2003.11.001","volume":"95","author":"H Cohen-Sacks","year":"2004","unstructured":"Cohen-Sacks, H. et al. Delivery and expression of pDNA embedded in collagen matrices. J. Control. Release 95, 309\u2013320 (2004).","journal-title":"J. Control. Release"},{"key":"125_CR187","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1006\/mthe.2002.0579","volume":"5","author":"J Doukas","year":"2002","unstructured":"Doukas, J. et al. Delivery of FGF genes to wound repair cells enhances arteriogenesis and myogenesis in skeletal muscle. Mol. Ther. 5, 517\u2013527 (2002).","journal-title":"Mol. Ther."},{"key":"125_CR188","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/9560","volume":"5","author":"T Ochiya","year":"1999","unstructured":"Ochiya, T. et al. New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet. Nat. Med 5, 707\u2013710 (1999).","journal-title":"Nat. Med"},{"key":"125_CR189","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0168-3659(02)00026-3","volume":"80","author":"Y Fukunaka","year":"2002","unstructured":"Fukunaka, Y., Iwanaga, K., Morimoto, K., Kakemi, M. & Tabata, Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J. Control. Release 80, 333\u2013343 (2002).","journal-title":"J. Control. Release"},{"key":"125_CR190","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0168-3659(03)00197-4","volume":"90","author":"T Kushibiki","year":"2003","unstructured":"Kushibiki, T., Tomoshige, R., Fukunaka, Y., Kakemi, M. & Tabata, Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J. Control. Release 90, 207\u2013216 (2003).","journal-title":"J. Control. Release"},{"key":"125_CR191","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jconrel.2003.10.011","volume":"94","author":"G Garcia del Barrio","year":"2004","unstructured":"Garcia del Barrio, G., Hendry, J., Renedo, M. J., Irache, J. M. & Novo, F. J. In vivo sustained release of adenoviral vectors from poly(D,L-lactic-co-glycolic) acid microparticles prepared by TROMS. J. Control. Release 94, 229\u2013235 (2004).","journal-title":"J. Control. Release"},{"key":"125_CR192","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymthe.2003.10.002","volume":"9","author":"RM Schek","year":"2004","unstructured":"Schek, R. M., Hollister, S. J. & Krebsbach, P. H. Delivery and protection of adenoviruses using biocompatible hydrogels for localized gene therapy. Mol. Ther. 9, 130\u2013138 (2004).","journal-title":"Mol. Ther."},{"key":"125_CR193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.02.032","volume":"204","author":"AM Thomas","year":"2015","unstructured":"Thomas, A. M., Palma, J. L. & Shea, L. D. Sponge-mediated lentivirus delivery to acute and chronic spinal cord injuries. J. Control. Release 204, 1\u201310 (2015).","journal-title":"J. Control. Release"},{"key":"125_CR194","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jconrel.2013.06.013","volume":"170","author":"AM Thomas","year":"2013","unstructured":"Thomas, A. M. & Shea, L. D. Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injury. J. Control. Release 170, 421\u2013429 (2013).","journal-title":"J. Control. Release"},{"key":"125_CR195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/10473","volume":"5","author":"J Bonadio","year":"1999","unstructured":"Bonadio, J., Smiley, E., Patil, P. & Goldstein, S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat. Med. 5, 753\u2013759 (1999).","journal-title":"Nat. Med."},{"key":"125_CR196","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.gt.3302439","volume":"12","author":"YC Huang","year":"2005","unstructured":"Huang, Y. C., Simmons, C., Kaigler, D., Rice, K. G. & Mooney, D. J. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther. 12, 418\u2013426 (2005).","journal-title":"Gene Ther."},{"key":"125_CR197","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.gt.3302940","volume":"14","author":"WW Hu","year":"2007","unstructured":"Hu, W. W., Wang, Z., Hollister, S. J. & Krebsbach, P. H. Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther. 14, 891\u2013901 (2007).","journal-title":"Gene Ther."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41584-018-0125-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-018-0125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41584-018-0125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:22:41Z","timestamp":1720830161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-018-0125-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":197,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.1038\/s41584-018-0125-2","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]},"assertion":[{"value":"4 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}